These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Anti-inflammatory cytokine TSG-6 inhibits hypertrophic scar formation in a rabbit ear model. Wang H; Chen Z; Li XJ; Ma L; Tang YL Eur J Pharmacol; 2015 Mar; 751():42-9. PubMed ID: 25661977 [TBL] [Abstract][Full Text] [Related]
43. [Study on the biological function of vascular endothelial cells in the hypertrophic scar]. Wang XQ; Lu SL; Mao ZG; Liu YK Zhonghua Shao Shang Za Zhi; 2007 Jun; 23(3):219-21. PubMed ID: 18019066 [TBL] [Abstract][Full Text] [Related]
44. Distinct properties of the recognition sites for beta-very low density lipoprotein (remnant receptor) and alpha 2-macroglobulin (low density lipoprotein receptor-related protein) on rat parenchymal cells. van Dijk MC; Kruijt JK; Boers W; Linthorst C; van Berkel TJ J Biol Chem; 1992 Sep; 267(25):17732-7. PubMed ID: 1381352 [TBL] [Abstract][Full Text] [Related]
45. Control of wound contraction. Basic and clinical features. Nedelec B; Ghahary A; Scott PG; Tredget EE Hand Clin; 2000 May; 16(2):289-302. PubMed ID: 10791174 [TBL] [Abstract][Full Text] [Related]
46. Expression of inflammatory and fibrogenetic markers in acne hypertrophic scar formation: focusing on role of TGF-β and IGF-1R. Yang JH; Yoon JY; Moon J; Min S; Kwon HH; Suh DH Arch Dermatol Res; 2018 Oct; 310(8):665-673. PubMed ID: 30167815 [TBL] [Abstract][Full Text] [Related]
47. Targeted apoptosis of myofibroblasts by elesclomol inhibits hypertrophic scar formation. Feng Y; Wu JJ; Sun ZL; Liu SY; Zou ML; Yuan ZD; Yu S; Lv GZ; Yuan FL EBioMedicine; 2020 Apr; 54():102715. PubMed ID: 32251998 [TBL] [Abstract][Full Text] [Related]
48. miR-205 inhibits the development of hypertrophic scars by targeting THBS1. Jiang D; Guo B; Lin F; Lin S; Tao K Aging (Albany NY); 2020 Nov; 12(21):22046-22058. PubMed ID: 33186919 [TBL] [Abstract][Full Text] [Related]
49. [Relationship between angiogenesis and expression of HO-1 of scar]. Zhu J; Luo CQ; He QY; Peng H; Zhou JD; Li P Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):335-9. PubMed ID: 16045028 [TBL] [Abstract][Full Text] [Related]
50. [Role of angiotensin II receptors in proliferation of fibroblast derived from human hypertrophic scars]. Liu HW; Cheng B; Yu WL; Sun RX; Tang JB; Fu XB Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Jan; 23(1):36-9. PubMed ID: 17393691 [TBL] [Abstract][Full Text] [Related]
51. [The role of myofibroblast in the development of pathological scar]. Liu Y; Cen Y; Ying T; Xu X Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jan; 19(1):39-41. PubMed ID: 15704840 [TBL] [Abstract][Full Text] [Related]
52. [Influences of human dermis derived mesenchymal stem cells on α-SMA and DCN expressions of hypertrophic scars fibroblasts]. Zhang W; Deng C; Guo C; Nie K; Tang X; Wei Z; Wang D Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):285-92. PubMed ID: 30044575 [TBL] [Abstract][Full Text] [Related]
53. The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP. Williams SE; Inoue I; Tran H; Fry GL; Pladet MW; Iverius PH; Lalouel JM; Chappell DA; Strickland DK J Biol Chem; 1994 Mar; 269(12):8653-8. PubMed ID: 7510694 [TBL] [Abstract][Full Text] [Related]
54. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327 [TBL] [Abstract][Full Text] [Related]
56. [Experimental and clinical study on treatment of hypertrophic scars with (90)Sr radiation]. Zhi Y; Fu JF; Yuan WH; Chen B; Li L; Wei Q; Tong Y Zhonghua Shao Shang Za Zhi; 2011 Dec; 27(6):416-21. PubMed ID: 22340786 [TBL] [Abstract][Full Text] [Related]
57. Pigment epithelium-derived factor attenuates angiogenesis and collagen deposition in hypertrophic scars. Ma D; Chen L; Shi J; Zhao Y; Vasani S; Chen K; Romana-Souza B; Henkin J; DiPietro LA Wound Repair Regen; 2020 Sep; 28(5):684-695. PubMed ID: 32585760 [TBL] [Abstract][Full Text] [Related]
58. Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway. Li Y; Zhang J; Zhou Q; Wang H; Xie S; Yang X; Ji P; Zhang W; He T; Liu Y; Wang K; Li X; Shi J; Hu D Exp Dermatol; 2019 Jan; 28(1):19-27. PubMed ID: 30308704 [TBL] [Abstract][Full Text] [Related]